Nuwellis (NUWE) EBITDA Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 16,623.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,623.00 |
| Dec 31, 2025 | -1,938.00 |
| Sep 30, 2025 | 20,838.00 |
| Jun 30, 2025 | -53,437.00 |
| Mar 31, 2025 | 7,394.00 |
| Dec 31, 2024 | 20,196.00 |
| Sep 30, 2024 | 38,396.00 |
| Jun 30, 2024 | -16,355.00 |
| Mar 31, 2024 | 3,871.00 |
| Dec 31, 2023 | -830.00 |
| Sep 30, 2023 | 8,439.00 |
| Jun 30, 2023 | -2,282.00 |
| Mar 31, 2023 | -7,477.00 |
| Dec 31, 2022 | 24,777.00 |
| Sep 30, 2022 | 17,275.00 |
| Jun 30, 2022 | 7,071.00 |
| Mar 31, 2022 | 15,687.00 |
| Dec 31, 2021 | 1,883.00 |
| Sep 30, 2021 | 2,671.00 |
| Jun 30, 2021 | 19,198.00 |
| Mar 31, 2021 | 14,740.00 |
| Dec 31, 2020 | 64,884.00 |
| Sep 30, 2020 | 7,349.00 |
| Jun 30, 2020 | 7,444.00 |
| Mar 31, 2020 | -17,599.00 |
| Dec 31, 2019 | 6,299.00 |
| Sep 30, 2019 | 36,240.00 |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 291,109.00 |
| Sep 30, 2017 | 1.01 Mn |
| Mar 31, 2017 | 1.07 Mn |
| Sep 30, 2016 | 978,601.00 |